Emerson (EMR) PT Raised to $112 at Morgan Stanley
Tweet
Share
E-mailGet Alerts EMR Hot Sheet
Price: $156.37 -0.78%
Rating Summary:
26 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Rating Summary:
26 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
Morgan Stanley analyst Chris Snyder raised the price target on Emerson (NYSE: EMR) to $112.00 (from $105.00) while maintaining a Underweight rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Hesai (2525:HK) (HSAI) PT Lowered to HK$24.20 at Macquarie
- Giant Biogene Holding Co (2367:HK) PT Raised to HK$46 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
